Our mission is to scale explanatory medical knowledge to support better decisions, research, and care provision.
Over time, this enables a learning health system where science, practice, and outcomes are more readily connected — collapsing the knowledge cycle.
Evidium is built by a multidisciplinary team of engineers, scientists and clinicians with deep experience across healthcare, AI and applied research.
Evidium is backed by investors specializing in both the science and practice of medicine and frontier technology. Our investors include Health2047, the venture studio of the American Medical Association; WGG Partners, a specialist deep tech fund with early-stage backing of x.AI and Perplexity; PGV, Interwoven Ventures and Mindset Ventures - plus multiple other specialist funds and individuals.